FyMed Inc



Specialty Diagnostics Providing Early Diagnosis and Proficient Treatment Response Strategies
New Developments
2015
New patent awarded to FyMed on novel immunomodulatory drug: Significant milestone strengthens intellectual property
2015
FyMed develops novel antineoplastic drug: Comparisons in tumor xenografts indicate substantial benefit
2014
Lead FyMed NSAID candidate FY103B: Studies demonstrate superiority over celecoxib and naproxen
2014
Comparative studies on FyMed NSAID candidates FY101C & FY103B: Results confirm profound clinical efficacy
2014
Examination of FyMed's clinical trial technologies: Precision medicine now peer reviewed as revolutionary
2013
Scientists at FyMed complete devpt of FY10 technology: Results reveal unique NSAID target profiles
2012
FyMed identifies new anti-inflammatory formulation: Studies show huge potential for new NSAID strategies
FyMed Events 2012
FyMed acquires MDT - Molecular Diagnostics & Therapeutics: Discovery studies now in full swing
Improving Clinical Outcomes with
Novel Molecular Therapeutics in Translational Medicine
About FyMed
Physicians and Scientists collaborate on several projects with FyMed. Our quest is to continue identification, characterization and development of novel biomarkers and promising therapeutic targets.

Leading innovations in precision medicine , has enabled FyMed to effectively balance technological innovation with scientific discovery, creating tools that can productively capitalize on key market deficiencies.

FyMed has established relationships with large companies, allowing us to collaborate and conduct clinical studies on a global scale. FyMed uses novel applications in bioinformatics and R&D tools that are closely integrated with the development of clinical studies enabling prolific product characterization and continued growth.

Our molecular-based precision medicine approach allows for targeting modalities with innovative techniques that are focused and comprehensive.

Now, you can be a part of this vital venture! Contact us if you would like to collaborate and utilize our proprietary methodologies in evidence-based medicine for drug discoveries.

Advancing Hope by Breakthrough Medical Research and Developing New Pathways to Cures
Medical News Today

FyMed, Inc.
Leading Innovations in Precision Medicine ™
Pharmaceuticals: 103 Carnegie Center Dr, #300, Princeton, NJ 08540
Corporate: 3422 Old Capitol Rd, #1610, Wilmington, DE 19808

USA Tel: +1 302-722-5010 | Fax: +1 302-722-5011
UK Tel: +44 1844 220 090 | ask@fymed.com

Copyright © FyMed, Inc.| All Rights Reserved